Patents by Inventor Norbert Redemann

Norbert Redemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted indolinones with kinase inhibitory activity
    Patent number: 6319918
    Abstract: Substituted indolinones of general formula having effect on various kinases and cycline/CDK complexes and on the proliferation of various tumour cells. Exemplary compounds are: 3-Z-[1-(4-(N-Benzyl-N-methyl-aminomethyl)-phenylamino)-1-methyl-methylene]-5-amido-2-indolinone and 3-Z-[1-(4-(2,3,4,5-Tetrahydro-benzo(d)azepin-3-yl-methyl)-phenylamino)-1-methyl-methylene]-5-amido-2-indolinone.
    Type: Grant
    Filed: June 1, 1999
    Date of Patent: November 20, 2001
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Armin Heckel, Rainer Walter, Wolfgang Grell, Jacobus C. A. van Meel, Norbert Redemann
  • Indolinones having kinase inhibitory activity
    Patent number: 6169106
    Abstract: The present invention relates to substituted indolinones of general formula wherein R1 to R5, and X are defined as in claim 1, the isomers thereof and the salts thereof, particularly the physiologically acceptable salts thereof which have valuable pharmacological properties, particularly an inhibitory effect on various kinases and cycline/CDK complexes and on the proliferation of various tumour cells, pharmaceutical compositions containing these (compounds, their use and processes for preparing them.
    Type: Grant
    Filed: April 6, 1999
    Date of Patent: January 2, 2001
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Armin Heckel, Rainer Walter, Wolfgang Grell, Jacobus C. A. van Meel, Norbert Redemann
  • Indolinones having kinase-inhibiting activity
    Patent number: 6043254
    Abstract: The present invention relates to indolinones of general formula ##STR1## wherein R.sub.1 to R.sub.3 are defined in claim 1, the isomers and the salts thereof, particularly the physiologically acceptable salts thereof which have valuable pharmacological properties, particularly an inhibiting effect on various kinases and cycline/CDK complexes and on the proliferation of various tumour cells, pharmaceutical compositions containing these compounds, their use and processes for preparing them.
    Type: Grant
    Filed: March 26, 1999
    Date of Patent: March 28, 2000
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Wolfgang Grell, Helmut Wittneben, Jacobus Constantinus Antonius van Meel, Norbert Redemann, Rainer Walter, Armin Heckel, Frank Himmelsbach, Robert Haigh